Preventive Medecine Flashcards
screenning test for pancreatic cancer
no test for that
why use ca 19-9
evaluation of the response to treatment
recommended vaccine in hiv(2)
the same guideline as normal individual
exception for live attenuated vaccine
When should be given Tetanos diphteria
q 10 ans
CAT in patient more than 65 ans who has never received tetanus toxoid
one dose of Tdap before receiving any booster
quid of Tdap(2)
tetanos
acellular petussis
smoking cessation(3)
bupropion
counselling
nicotine replacement
quid of bupropion(2)
antidepressant
approved by FDA
other drug used in smoking cessation and action.(2)
varenicline
partial agonist of nicotinic acetylcholine receptor
patient with anti HBS-antibody positive has AES in patient positive for Hep B CAT?
do nothing
patient with with unknown statut has AES in patient positive for Hep B CAT?
Immune globulin
vaccination series for Hep B
CAT in patient diabetic 40-75 ans with ten year cardiovascular risk <7,5(2)
lifestyle modification
moderate statin use
when to begin prostate screening(3)
controversy
some say 40
some say case by case approach
screening of prostate cancer(2)
Psa
digital exam
recommendation for tetanos and diphteria prevention
starting after 18
TD q 10 ans
or for all ages Tdap at single dose
indication of pneumococcal vaccine in < 65 ans(10
chronic lung disease chronic CV disease diabetes mellitus chronic liver disease immunocpmpromised patient functional or anatomic asplenia alcoholism cigarette cochlear inplant CSF leak
quid of chronic lung disease(3)
asthme
bronchite chronique
emphysema
cause of functionnal asplenia(4)
sickle cell disease
hemoglobinopathy
splenectomy
acquired asplenism
people who can receive intranasal influenza
healthy individual
people who cant receive intranasal influenza
what should be given
immunocompromised patient
intramuscular influenza vaccine
way to prevent decubitus ulcer(2)
change position q 2h
pressure reducing devices
patient at risk for decubitus ulcer(3)
immobility
poor nutrition
sensory impairment
quid of pressure reducing devices
air and foam mattress
when to screen breast cancer and when to start
q 2 ans
starting 50
when generally breast cancer is no more important
after 75
when to screen cervical cancer and when start(2)
q 3 ans
21 ans
frequency of screening for cervical cancer in 30-65 ans
q 5 ans
par smear et serology HPV
when to screen cervical cancer in immunocompromised patient(hiv,tranplanted or immunosuppresive drug)and frequency(2)
at the onset of sexual activity
annually but twice in the first year
screening for colon cancer in patient with parent killed by the ca
begin ten years earlier
screening for colon cancer in patient in general and frequency(2)
50 ans
q 10 ans
way of screening colon cancer(5)
fecal occult blood in feces colonoscopy Flexible sigmoidoscopy FOBT plus flexible sigmoidoscopy double contrast bayum enema
patient with cd4 less than 200 what vaccines should not be done to this patient
MMR
varicella
zoster
intranasal influenza
dose of Hep A vaccine in HIV patient or in general(2)
2 doses
the second a 6 mois de la premiere dose
dose of hep B in HIV or in general situation
3 doses
o month,1 month,4 month
frequency of Hi flu
one dose in infancy
best rx for claudication
exercice program
what should receive any patient with atherosclerotic risk(2)
PAD
statin
aspirin
criteria to scren abdominal aneurism
smoker
> 65
frequency of screening for abdominal aneurism
one time
way of screening abdominal aneurism
U/S
number of dose of PPSV(pneumonia vaccine)(2)
1 or 2(repeat in 5 yars)
more than 65 years one dose
patient going to egypt important vaccine to be given(or north africa or any developing country)(4)
-Hep A
Hep B
typhoide
Polyo
CAT in patient with atherosclerotic risk disease 75 ans
high intensity statin
CAT in patient with atherosclerotic risk disease > 75 ans
moderate intensity statin
quid of atherosclerotic disease(3)
stroke
pad
CAD
CAT in LDL >/190 mg/dl
high intensity statin
diabetic entre 40-75 ans patient with 10 year atherosclerotic cardiovascular risk >/ 7,5
high intensity statin
diabetic entre 40-75 ans patient with 10 year atherosclerotic cardiovascular risk < 7,5
moderate intensity statin
patient with 10 year atherosclerotic cardiovascular risk >/ 7,5
moderate to high intensity statin
prevention of influenza in immunocompromised patient
IM influenza vaccine
mechanism of action of pneumococcal pneumoniae prevention using the polyvalent pneumococcal vaccine
T-cell independent B cell response
why polyvalent pneumococal vaccine cannot activate T cell(2)
because it’s just polysaccharides of the 23 most prevalent types of pneumococcus
polysaccharides cannot be presented to t cell
quid of heptavalent pneumococcus vaccine(2)
use in children
t cell dependent b cell response
screnning test in any sexually active women
chlamydia trachomatis
risk for bladder cancer(2)
smoking
industrial chemical
screening of bladder cancer
no screening
when to screen patient for osteoporosis
starting after 65 ans
quid of osteoporosis
bone density > 2,5 of standard deviation or
T
quid of osteopenia
T entre -1 et -2,5
the most important risk factor for osteoporosis in the US
post menopause
risk factor for osteoporosis(6)
poor intake of VitD and calcium smoking common steroid use lack of weight bearing exercice low body mass index < 58 kg heavy alcohol use
secondary cause of osteoporosis(11)
premature menopause hypogonadism malabsorption disease IBD rhumatoid arthritis cushing syndrome hyperthyroidism hyperparathyroidism vit D deficiency chronic liver disese renal disease
screening test for hyperlipidemia in men when to start and frequency(2)
> 35 ans
lipid panel q 5 ans
when mamo is no longer important in screening breast ca
after 75 ans
high intensity statin(2)
atorvastatin 40-80
rosuvastatin 20-40 mg
moderate intensity statin(5)
atorvastatin 10-20 mg rosuvastatin 5-10 simvastatin 20-40 pravastatin 40-80 lovastatin 40
